Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.57 |
| ▸ | IDO1 | P14902 | 2/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 7/20 | 0.56 |
| ▸ | DAO | P14920 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29915506 | 1.00 | MAOB (0.57) | MAOBIDO1TAAR1DAOHTR2A | |
| Hydrochloric Acid SCHEMBL6944674 | 0.98 | MAOB (0.59) | MAOBIDO1TAAR1DAOHTR2A | |
| Iodide SCHEMBL28682742 | 0.98 | MAOB (0.55) | MAOBIDO1TAAR1DAOHTR2A | |
| SCHEMBL7569592 | 0.89 | TAAR1 (0.69) | MAOBIDO1TAAR1DAOHTR2A | |
| SCHEMBL2096671 | 0.88 | IDO1 (0.53) | MAOBIDO1TAAR1DAOALDH1A1 | |
| Acetic Acid SCHEMBL10562647 | 0.88 | POLQ (0.50) | MAOBIDO1TAAR1ALDH1A1POLB | |
| SCHEMBL17329111 | 0.86 | IDO1 (0.59) | MAOBIDO1DAOALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL15969655 | 0.86 | IDO1 (0.55) | MAOBIDO1TAAR1DAOALDH1A1 | |
| SCHEMBL6236119 | 0.84 | IDO1 (0.50) | MAOBIDO1TAAR1DAOALDH1A1 | |
| SCHEMBL43013 | 0.82 | IDO1 (0.61) | MAOBIDO1DAOALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119410231-A | Preparation method of soft and hard composite low-icing-adhesion anti-icing coating | 国网山东省电力公司莱芜供电公司 | 2025-02-11 | — | — | CN | claimed |
| CN-115057883-B | Two-dimensional perovskite white light material and preparation method and application thereof | 吉林大学 | 2024-05-17 | — | — | CN | claimed |
| CN-112079775-B | Synthesis method of 5-trifluoromethyl isoquinoline-8-formic acid | 苏州康润医药有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-115057883-A | Two-dimensional perovskite white light material and preparation method and application thereof | 吉林大学 | 2022-09-16 | — | — | CN | claimed |
| CN-113512029-A | Preparation and application of substituted pyrazole compound containing pyrimidinamine | 沈阳中化农药化工研发有限公司 | 2021-10-19 | — | — | CN | claimed |
| CN-101410366-A | Substituted bicyclic ring derivatives and uses thereof | ASAHI KASEI PHARMA CORP (JP) | 2009-04-15 | — | — | CN | claimed |
| EP-4725942-A1 | COMPOUNDS ACTIVE ON CYCLIN D1 PATHWAY AND THEIR USE | Sibylla Biotech S.p.A. (IT) | 2026-04-15 | — | — | EP | disclosed |
| US-12428416-B2 | ERK inhibitors and uses thereof | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2025-09-30 | — | — | US | disclosed |
| CN-119410231-B | Preparation method of soft and hard composite low-icing-adhesion anti-icing coating | 国网山东省电力公司莱芜供电公司 | 2025-08-15 | — | — | CN | disclosed |
| US-20250136545-A1 | NOVEL SULFONAMIDE DERIVATIVES HAVING SELECTIVE NOX INHIBITING ACTIVITY | GLUCOX BIOTECH AB (SE) | 2025-05-01 | — | — | US | disclosed |
| CN-119410231-A | Preparation method of soft and hard composite low-icing-adhesion anti-icing coating | 国网山东省电力公司莱芜供电公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-119410231-A | Preparation method of soft and hard composite low-icing-adhesion anti-icing coating | 国网山东省电力公司莱芜供电公司 | 2025-02-11 | — | — | CN | disclosed |
| EP-4499629-A1 | BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS | Oncopia Therapeutics, Inc. D/B/A SK Life Science Labs (US) | 2025-02-05 | — | — | EP | disclosed |
| US-5294622-A | Fungicides, insecticides, miticides | DOWELANCO (US) | 1994-03-15 | — | — | US | disclosed |
| EP-0563132-A1 | TETRAPEPTIDE DERIVATIVES AND ANALOGUES. | BLACK JAMES FOUNDATION (GB) | 1993-10-06 | — | — | EP | disclosed |
| WO-1992011284-A1 | TETRAPEPTIDE DERIVATIVES AND ANALOGUES | THE JAMES BLACK FOUNDATION LIMITED (GB) | 1992-07-09 | — | — | WO | disclosed |
| US-5114939-A | Amine or ether substitutes compounds of quinoline or cinnoline | DOWELANCO (US) | 1992-05-19 | — | — | US | disclosed |
| US-4857553-A | SIDE EFFECT REDUCTION | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-08-15 | — | — | US | disclosed |
| EP-0326331-A2 | Substituted quinolines and cinnolines | DowElanco (US) | 1989-08-02 | — | — | EP | disclosed |
| EP-0302757-A2 | Anti-emetic serotonin depleting agents | A.H. ROBINS COMPANY, INCORPORATED (US) | 1989-02-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250136545-A1 | NOVEL SULFONAMIDE DERIVATIVES HAVING SELECTIVE NOX INHIBITING ACTIVITY | NOX4, NOX1, NOX5 | MAOB 444/4885IDO1 2932/4885TAAR1 2787/4885 |
| US-12428416-B2 | ERK inhibitors and uses thereof | MAPKAPK2, MAPK3, MAP4K2 | MAOB 3835/4885IDO1 4525/4885TAAR1 4313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.